| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $561.2M | $449.6M | $359.6M |
| YoY Revenue Growth % | +24.8% | +25.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $359.9M | $278.2M | $242.8M |
| Operating Margin % | 64.1% | 61.9% | 67.5% |
| Net Income (GAAP) | $253.0M | $203.0M | $190.7M |
| EBITDA (Normalized) | $380.1M | $294.4M | $255.7M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $381.1M | $308.5M | $254.6M |
| Capital Expenditures (CapEx) | $25.3M | $20.2M | $16.2M |
| Free Cash Flow (FCF) | $355.8M | $288.3M | $238.4M |
| FCF Margin % | 63.4% | 64.1% | 66.3% |
| Return on Invested Capital (ROIC %) | 5.3% | 4.9% | 9.8% |
| Cash & Short-Term Equivalents | $60.2M | $40.7M | — |
| Total Debt (Short + Long Term) | $1.19B | $1.00B | $757.8M |
| Total Stockholders' Equity | $4.20B | $3.56B | $1.55B |